Shoulder Innovations (NYSE:SI) Major Shareholder Sells $88,140.00 in Stock

Shoulder Innovations, Inc. (NYSE:SIGet Free Report) major shareholder Healthcare Holding B.V. Gilde sold 3,900 shares of the business’s stock in a transaction on Thursday, August 20th. The stock was sold at an average price of $22.60, for a total value of $88,140.00. Following the sale, the insider owned 2,208,307 shares in the company, valued at approximately $49,907,738.20. The trade was a 0.18% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available through this link. Large shareholders that own at least 10% of a company’s shares are required to disclose their sales and purchases with the SEC.

Healthcare Holding B.V. Gilde also recently made the following trade(s):

  • On Monday, August 24th, Healthcare Holding B.V. Gilde sold 681 shares of Shoulder Innovations stock. The shares were sold at an average price of $22.62, for a total value of $15,404.22.
  • On Friday, August 21st, Healthcare Holding B.V. Gilde sold 20,516 shares of Shoulder Innovations stock. The stock was sold at an average price of $22.61, for a total value of $463,866.76.
  • On Thursday, August 6th, Healthcare Holding B.V. Gilde sold 2,095 shares of Shoulder Innovations stock. The shares were sold at an average price of $22.60, for a total transaction of $47,347.00.
  • On Wednesday, August 5th, Healthcare Holding B.V. Gilde sold 7,338 shares of Shoulder Innovations stock. The shares were sold at an average price of $22.64, for a total transaction of $166,132.32.
  • On Tuesday, August 4th, Healthcare Holding B.V. Gilde sold 99,812 shares of Shoulder Innovations stock. The stock was sold at an average price of $22.77, for a total transaction of $2,272,719.24.
  • On Monday, August 3rd, Healthcare Holding B.V. Gilde sold 10,751 shares of Shoulder Innovations stock. The shares were sold at an average price of $22.71, for a total transaction of $244,155.21.
  • On Friday, July 31st, Healthcare Holding B.V. Gilde sold 20,034 shares of Shoulder Innovations stock. The shares were sold at an average price of $22.73, for a total transaction of $455,372.82.
  • On Thursday, July 30th, Healthcare Holding B.V. Gilde sold 28,245 shares of Shoulder Innovations stock. The stock was sold at an average price of $23.36, for a total transaction of $659,803.20.

Shoulder Innovations Trading Up 0.6%

Shares of Shoulder Innovations stock opened at $22.45 on Thursday. Shoulder Innovations, Inc. has a 1 year low of $10.92 and a 1 year high of $24.59. The company has a debt-to-equity ratio of 0.12, a current ratio of 10.71 and a quick ratio of 8.92. The business has a 50 day moving average price of $21.19 and a 200 day moving average price of $16.73. The company has a market capitalization of $467.39 million and a P/E ratio of -11.69.

Shoulder Innovations (NYSE:SIGet Free Report) last announced its earnings results on Thursday, August 6th. The company reported ($0.49) EPS for the quarter, missing analysts’ consensus estimates of ($0.46) by ($0.03). The company had revenue of $17.18 million for the quarter. Shoulder Innovations had a negative net margin of 58.33% and a negative return on equity of 23.61%. Sell-side analysts anticipate that Shoulder Innovations, Inc. will post -1.9 EPS for the current fiscal year.

Institutional Inflows and Outflows

Several large investors have recently modified their holdings of SI. California State Teachers Retirement System boosted its position in shares of Shoulder Innovations by 412.4% in the second quarter. California State Teachers Retirement System now owns 2,941 shares of the company’s stock worth $60,000 after acquiring an additional 2,367 shares during the last quarter. Compass Financial Management LLC acquired a new position in shares of Shoulder Innovations in the 2nd quarter valued at $30,000. Bank of America Corp DE increased its holdings in shares of Shoulder Innovations by 43.7% during the 1st quarter. Bank of America Corp DE now owns 26,983 shares of the company’s stock worth $392,000 after buying an additional 8,205 shares during the last quarter. Royal Bank of Canada raised its position in shares of Shoulder Innovations by 7,046.3% in the 1st quarter. Royal Bank of Canada now owns 53,883 shares of the company’s stock worth $783,000 after buying an additional 53,129 shares during the period. Finally, KCM Capital Inc acquired a new position in Shoulder Innovations in the first quarter valued at $509,000.

Wall Street Analysts Forecast Growth

Several equities research analysts have issued reports on SI shares. Piper Sandler reaffirmed an “overweight” rating and set a $25.00 price target (up from $19.00) on shares of Shoulder Innovations in a research note on Friday, August 7th. Weiss Ratings raised shares of Shoulder Innovations from a “sell (d-)” rating to a “sell (d)” rating in a research note on Monday, August 3rd. UBS Group raised their target price on shares of Shoulder Innovations from $27.00 to $28.00 and gave the stock a “buy” rating in a research report on Monday, August 10th. Finally, BTIG Research lifted their target price on shares of Shoulder Innovations from $24.00 to $26.00 and gave the stock a “buy” rating in a research note on Friday, August 7th. Five analysts have rated the stock with a Buy rating and one has assigned a Sell rating to the stock. According to data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and an average target price of $25.50.

Get Our Latest Report on SI

Shoulder Innovations Company Profile

(Get Free Report)

Shoulder Innovations (NYSE:SI) is a medical device company focused on the design, development and commercialization of shoulder implant systems and related surgical instruments for orthopedic surgery. The company’s product portfolio includes modular shoulder prostheses, humeral and glenoid components, and instrumentation kits designed to facilitate both primary and revision shoulder arthroplasty procedures. Emphasizing a patient-centric approach, Shoulder Innovations works to offer implant solutions that aim to restore mobility and reduce post-operative complications.

In addition to its core implant offerings, Shoulder Innovations provides comprehensive clinical support and training programs for surgeons and operating room teams.

Featured Articles

Insider Buying and Selling by Quarter for Shoulder Innovations (NYSE:SI)

Receive News & Ratings for Shoulder Innovations Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Shoulder Innovations and related companies with MarketBeat.com's FREE daily email newsletter.